Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins
- PMID: 17696517
- DOI: 10.1021/pr070204f
Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins
Abstract
Antibody-based microarrays is a novel technology with great promise for high-throughput proteomics. The process of designing high-performing arrays has, however, turned out to be challenging. Here, we have designed the next generation of a human recombinant scFv antibody microarray platform for protein expression profiling of nonfractionated biotinylated human plasma and serum proteomes. The setup, based on black polymer Maxisorb slides interfaced with a fluorescent-based read-out system, was found to provide specific, sensitive (subpicomolar (pM) range) and reproducible means for protein profiling. Further, a chip-to-chip normalization protocol critical for comparing data generated on different chips was devised. Finally, the microarray data were found to correlate well with clinical laboratory data obtained using conventional methods, as demonstrated for a set of medium abundant (micromolar (microM) to nanomolar (nM) range) protein analytes in serum and plasma samples derived from healthy and complement-deficient individuals.
Similar articles
-
Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support.Proteomics. 2007 Sep;7(17):3055-65. doi: 10.1002/pmic.200700025. Proteomics. 2007. PMID: 17787036
-
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.Eur J Cancer. 2008 Feb;44(3):472-80. doi: 10.1016/j.ejca.2007.11.025. Epub 2008 Jan 2. Eur J Cancer. 2008. PMID: 18171612
-
Design of recombinant antibody microarrays for cell surface membrane proteomics.J Proteome Res. 2008 Jan;7(1):319-27. doi: 10.1021/pr070257x. Epub 2007 Nov 30. J Proteome Res. 2008. PMID: 18047267
-
Progress in miniaturization of protein arrays--a step closer to high-density nanoarrays.Drug Discov Today. 2007 Oct;12(19-20):813-9. doi: 10.1016/j.drudis.2007.08.003. Epub 2007 Sep 18. Drug Discov Today. 2007. PMID: 17933681 Review.
-
High-throughput proteomics using antibody microarrays: an update.Expert Rev Mol Diagn. 2007 Sep;7(5):673-86. doi: 10.1586/14737159.7.5.673. Expert Rev Mol Diagn. 2007. PMID: 17892372 Review.
Cited by
-
Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding Nanowires.Nanomaterials (Basel). 2021 Jan 16;11(1):227. doi: 10.3390/nano11010227. Nanomaterials (Basel). 2021. PMID: 33467141 Free PMC article.
-
Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.Mol Oncol. 2016 Oct;10(8):1305-16. doi: 10.1016/j.molonc.2016.07.001. Epub 2016 Jul 12. Mol Oncol. 2016. PMID: 27522951 Free PMC article.
-
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.Proteome Sci. 2009 Apr 6;7:15. doi: 10.1186/1477-5956-7-15. Proteome Sci. 2009. PMID: 19348683 Free PMC article.
-
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.Proteomics Clin Appl. 2014 Dec;8(11-12):951-62. doi: 10.1002/prca.201300059. Epub 2014 Oct 22. Proteomics Clin Appl. 2014. PMID: 25196118 Free PMC article.
-
Tumor tissue protein signatures reflect histological grade of breast cancer.PLoS One. 2017 Jun 26;12(6):e0179775. doi: 10.1371/journal.pone.0179775. eCollection 2017. PLoS One. 2017. PMID: 28650989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources